Drug
prabotulinumtoxinA-xvfs
prabotulinumtoxinA-xvfs is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
33%(1 trials)
Phase Distribution
Ph early_phase_1
1
25%
Ph phase_2
1
25%
Ph phase_4
1
25%
Ph phase_1
1
25%
Phase Distribution
2
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(3)
Detailed Status
Completed3
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Early Phase 11 (25.0%)
Phase 11 (25.0%)
Phase 21 (25.0%)
Phase 41 (25.0%)
Trials by Status
completed375%
recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
recruitingphase_4
BoTox Into the Sternocleidomastoid Muscles (SCM)
NCT06903975
completedphase_1
Effects of Microtox on Facial Skin Quality, Fine Wrinkles, and Texture
NCT06604832
completedphase_2
Study to Demonstrate Safety and Duration of Effect of 40 Units of PrabotulinumtoxinA-xvfs to Treat Glabellar Lines
NCT05320393
completedearly_phase_1
Spread of PrabotulinumtoxinA-xvfs Versus OnabotulinumtoxinA in the Treatment of Forehead Rhytides
NCT05807412
Clinical Trials (4)
Showing 4 of 4 trials
NCT06903975Phase 4
BoTox Into the Sternocleidomastoid Muscles (SCM)
NCT06604832Phase 1
Effects of Microtox on Facial Skin Quality, Fine Wrinkles, and Texture
NCT05320393Phase 2
Study to Demonstrate Safety and Duration of Effect of 40 Units of PrabotulinumtoxinA-xvfs to Treat Glabellar Lines
NCT05807412Early Phase 1
Spread of PrabotulinumtoxinA-xvfs Versus OnabotulinumtoxinA in the Treatment of Forehead Rhytides
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4